B. Kenneth Koe - Concepedia

Author

B. Kenneth Koe

Also Known As

B K Koe, B KOE, B Kenneth Koe, B. K. KOE, B. K. Koe, B. KENNETH KOE, B. Kenneth Koe, B.K. Koe, B.KENNETH KOE, B.Kenneth Koe

100

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)California Institute of Technology

About

B. Kenneth Koe is an author at Pfizer (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	1.5K
2	Natural Sciences	10	11	623
3	Social Sciences	10	10	392
4	Engineering	3	3	67
5	Health Sciences	3	3	121

B. Kenneth Koe

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
p-CHLOROPHENYLALANINE: A SPECIFIC DEPLETOR OF BRAIN SEROTONIN B. Kenneth Koe, Albert Weissman Journal of Pharmacology and Experimental Therapeutics	1966	1.8K
Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. B. Kenneth Koe Journal of Pharmacology and Experimental Therapeutics	1976	500
ANTIAMPHETAMINE EFFECTS FOLLOWING INHIBITION OF TYROSINE HYDROXYLASE Albert Weissman, B. Kenneth Koe, S. S. Tenen Journal of Pharmacology and Experimental Therapeutics	1966	452
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants Reinhard Sarges, Harry Howard, Ronald G. Browne, Journal of Medicinal Chemistry	1990	407
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH, Journal of Pharmacology and Experimental Therapeutics	1983	257
Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins Willard M. Welch, Allen R. Kraska, Reinhard Sarges, Journal of Medicinal Chemistry PsychopharmacologyPharmacotherapyMolecular PharmacologyMedicinal ChemistrySerotonin Reuptake	1984	218
Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds B. L. CHENARD, Ismail A. Shalaby, B. Kenneth Koe, Journal of Medicinal Chemistry	1991	141
Behavioral effects of -α-methyltyrosine, an inhibitor of tyrosine hydroxylase A. Weissman, B. Kenneth Koe Life Sciences Molecular PharmacologyTyrosine HydroxylaseBehavioral NeuroscienceMedicineBehavioural Pharmacology	1965	132
Biochemical and behavioral studies of the 5‐HT<sub>1B</sub> receptor agonist, CP‐94,253 B. Kenneth Koe, Jann A. Nielsen, John E. Macor, Drug Development Research Food IntakePharmacotherapySaturation StudiesExperimental PharmacologyMolecular Pharmacology	1992	108
The Pharmacology of para-Chlorophenylalanine, a Selective Depletor of Serotonin Stores B. Kenneth Koe, A. Weissman Advances in pharmacology BiochemistryMedicineNeurotransmitterPsychopharmacologyNeuropharmacology	1968	108

Page 1